Skip to main navigation Skip to search Skip to main content

Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374

Research output: Contribution to journal › Comment/debate

95 Downloads (Pure)
Original languageEnglish
Article number1084
Number of pages2
JournalCancers
Volume16
Issue number6
DOIs
Publication statusPublished - 7 Mar 2024

Bibliographical note

Correction to Bailey, S.; André, N.; Gandola, L.; Massimino, M.; Wheatley, K.; Gates, S.; Homer, V.; Rutkowski, S.; Clifford, S.C. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374. https://doi.org/10.3390/cancers14020374

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this